00570 中國中藥
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
08/04/2025中國醫藥集團有限公司1101(L)+50,350,000(L)HKD 1.864(L)1,685,055,642(L)33.46
23/10/2024UBS Group AG1704(L)-125,370,747(L)151,708,526(L)3.01
23/10/2024JPMorgan Chase & Co.1704(L)-85,178,952(L)HKD 2.478(L)190,328,504(L)
83,381,177(S)
10,982,140(P)		3.77
1.65
0.21
22/10/2024Athos Capital Limited1201(L)-13,144,000(L)HKD 2.532(L)251,268,353(L)4.99
22/10/2024Millennium Management LLC1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Moskey Matthew Love1201(L)-13,144,000(L)HKD 2.532(L)251,268,353(L)4.99
22/10/2024MLM Trust B LLC1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024UBS Group AG1213(L)
15014(S)		-71,975,361(L)
-88,020,000(S)		282,077,273(L)
42,926,000(S)		5.60
0.85
22/10/2024Millennium Offshore Intermediate, L.P.1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Millennium International, Ltd.1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Schulte-Hillen Friedrich Bela1201(L)-13,144,000(L)HKD 2.532(L)251,268,353(L)4.99
22/10/2024Integrated Core Strategies (Asia) Pte. Ltd.1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Integrated Holding Group LP1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Millennium Partners, L.P.1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Englander Israel Alexander1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Millennium Group Management LLC1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
22/10/2024Rohr George1704(L)-29,467,000(L)HKD 3.809(L)246,174,549(L)
6,000(S)		4.89
0.00
21/10/2024Athos Capital Limited1001(L)+30,000,000(L)HKD 2.382(L)264,412,353(L)5.25
21/10/2024Moskey Matthew Love1001(L)+30,000,000(L)HKD 2.382(L)264,412,353(L)5.25
21/10/2024Schulte-Hillen Friedrich Bela1001(L)+30,000,000(L)HKD 2.382(L)264,412,353(L)5.25
18/10/2024JPMorgan Chase & Co.1004(L)
1403(S)		+30,631,227(L)
+22,228,763(S)		HKD 3.837(L)278,894,757(L)
81,424,711(S)
14,960,141(P)		5.53
1.61
0.29
17/10/2024JPMorgan Chase & Co.1704(L)-14,574,099(L)HKD 3.929(L)248,263,530(L)
59,195,948(S)
14,960,141(P)		4.92
1.17
0.29
16/10/2024JPMorgan Chase & Co.1001(L)
1403(S)		+19,857,236(L)
+4,626,836(S)		HKD 4.334(L)262,837,629(L)
58,442,384(S)
14,960,141(P)		5.21
1.16
0.29
15/10/2024UBS Group AG1205(L)-15,500,000(L)396,556,886(L)
130,946,000(S)		7.87
2.60
27/09/2024UBS Group AG1305(L)9,639,008(L)409,029,730(L)
130,946,000(S)		8.12
2.60
24/09/2024Millennium Partners, L.P.1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Englander Israel Alexander1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024MLM Trust B LLC1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Millennium Offshore Intermediate, L.P.1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Millennium International, Ltd.1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Integrated Holding Group LP1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Millennium Group Management LLC1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Rohr George1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Integrated Core Strategies (Asia) Pte. Ltd.1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
24/09/2024Millennium Management LLC1001(L)+4,648,000(L)HKD 4.318(L)254,912,549(L)5.06
 1  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.